I didn't hear that. He was asked about GBM but DIPG is what he...

I didn't hear that. He was asked about GBM but DIPG is what he was commenting on.

What I got is that ONC201 and Pax were a good starting point for a more complex treatment regime which is as yet unknown.
He considers that they have compressed ten years work into four years, and there is so much more work to do.
They are at the beginning of addressing a very complex issue.
(there was even something for Hopper and others, with repeated mention of possible subsequent use of of Car-T therapy down the track.)
Meantime, he has to spend January doing funding applications, otherwise the work of he and his team could end.